Navigation Links
Cardium Presents Third Quarter 2012 Financial Results and Reports on Recent Developments
Date:11/14/2012

/p>

About CardiumCardium is an asset-based health sciences and regenerative medicine company focused on the acquisition and strategic development of innovative products and businesses with the potential to address significant unmet medical needs and having definable pathways to commercialization, partnering or other economic monetizations. Cardium's current portfolio includes the Tissue Repair Company, Cardium Biologics, and the Company's newly-acquired To Go Brands® healthy nutraceutical supplement business. The Company's lead commercial product Excellagen® topical gel for wound care management has received FDA clearance for marketing and sale in the United States.  Cardium's lead clinical development product candidate Generx® is a DNA-based angiogenic biologic intended for the treatment of patients with myocardial ischemia due to coronary artery disease. To Go Brands develops, markets and sells dietary supplements through established regional and national retailers.  In addition, consistent with its capital-efficient business model, Cardium continues to actively evaluate new technologies and business opportunities. News from Cardium is located at www.cardiumthx.com.

Forward-Looking Statements  

Except for statements of historical fact, the matters discussed in this press release are forward looking and reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control and may cause actual results to differ materially from expectations. For example, there can be no assurance that results or trends observed in one clinical study or procedure will be reproduced in subsequent studies or in actual use; that new clinical studies will be successful or will lead to approvals or clearances from health regulatory authorities, or that approvals in one jurisdiction will help to support studies or approvals el
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Cardium Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care
2. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
3. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
4. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
5. Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments
6. Cardium Announces Excellagen Poster Presentatons At Desert Foot 9th Annual High Risk Diabetic Foot Conference
7. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
8. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
9. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
10. Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
11. Boston Scientific Endoscopy Presents Promising Clinical Data During Digestive Disease Week ®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2, 2014  XBiotech announced today interim results ... in the US for its anti-cancer agent Xilonix™. ... therapy, is being evaluated in advanced colorectal cancer ... The primary endpoint of the study is overall ... a control population provided only palliative therapy for ...
(Date:9/2/2014)... CALGARY, Alberta , September 2, 2014 ... of the Art and Featured Research Session" beim Kongress ... (TSX: RVX) gab heute bekannt, dass Dr. Jan Johansson, Senior ... des europäischen Kardiologenverbandes (ESC) 2014 in Barcelona ... Vortrag mit dem Titel " Effects of RVX-208 on ...
(Date:9/2/2014)... Reportlinker.com announces that a new market ... Acute Heart Failure Global Clinical Trials Review, ... Acute Heart Failure Global Clinical Trials ... clinical trial report, "Acute Heart Failure Global Clinical ... Acute Heart Failure clinical trial scenario. This report ...
Breaking Medicine Technology:XBiotech Halts Study, Reports Positive Phase III Results with Antibody Therapy for Cancer 2RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 2RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 3RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 4RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 5RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 6Acute Heart Failure Global Clinical Trials Review, H2, 2014 2Acute Heart Failure Global Clinical Trials Review, H2, 2014 3Acute Heart Failure Global Clinical Trials Review, H2, 2014 4Acute Heart Failure Global Clinical Trials Review, H2, 2014 5Acute Heart Failure Global Clinical Trials Review, H2, 2014 6Acute Heart Failure Global Clinical Trials Review, H2, 2014 7Acute Heart Failure Global Clinical Trials Review, H2, 2014 8
(Date:9/2/2014)... (PRWEB) September 02, 2014 Anti-aging ... products and services such as anti-wrinkle treatments and ... based treatments, and breast augmentation becoming much sought ... by U.S.-based market intelligence firm Transparency Market Research, ... products will grow to USD 191.7 billion by ...
(Date:9/2/2014)... September 02, 2014 Evolve Medical ... the primary and urgent care arena, is having ... coincides with a health fair the clinic is ... technology to assist patients in achieving high quality, ... Clinics’ pricing structure is a groundbreaking change in ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 When weather conditions ... day or night, leaving behind a path of destruction. In ... with an average of 1,253 tornadoes per year. Rainbow International ... in case a tornado strikes., , Select ... interior room in your home with no windows to stay ...
(Date:9/2/2014)... CITY, GA (PRWEB) September 02, 2014 Last ... whole new level with the launch of a luxurious line ... to announce that the SEA ISLAND COTTON Socks are joining ... compression level, giving more people the comfort of natural cotton ... COTTON Socks, they are surprised to find socks as soft ...
(Date:9/2/2014)... New York (PRWEB) September 02, 2014 ... of the DePuy Pinnacle hip implant ( http://www.depuypinnacle-lawsuit.com/depuy-pinnacle-hip-implant/ ... begins today in the U.S. District Court, Northern ... to court documents, Johnson & Johnson and its ... that allege the all-metal hip caused recipients to ...
Breaking Medicine News(10 mins):Health News:Global Anti-aging Market Research Report 2018 by Transparency Market Research 2Health News:Global Anti-aging Market Research Report 2018 by Transparency Market Research 3Health News:Evolve Medical Clinics Announces Grand Opening of Annapolis, Maryland Location 2Health News:Evolve Medical Clinics Announces Grand Opening of Annapolis, Maryland Location 3Health News:Act Quickly in Case of Tornado: Rainbow International® Offers Tips on How to Be Prepared for a Tornado 2Health News:SIGVARIS’ Luxury Line of Compression Socks, SEA ISLAND COTTON, Now Available in Stronger Compression Level 2Health News:DePuy Pinnacle Lawsuit Set For Trial in Federal Litigation, as Jury Selection Begins Today, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Lawsuit Set For Trial in Federal Litigation, as Jury Selection Begins Today, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Lawsuit Set For Trial in Federal Litigation, as Jury Selection Begins Today, Bernstein Liebhard LLP Reports 4
... HealthDay Reporter , TUESDAY, Aug. 24 (HealthDay News) -- ... by a U.S. judge to halt any expansion ... temporary injunction, which basically blindsided the scientific community, effectively ... days. That was when then-President Bush ordered that federal ...
... people lose weight and body fat when they exercise and eat ... (MR) spectroscopy can provide the answer and help predict who ... online and will appear in the November issue of the journal ... the same and have the same body mass index (BMI), but ...
... HealthDay Reporter , TUESDAY, Aug. 24 (HealthDay News) -- ... a day boost a woman,s odds of premature delivery? ... The researchers looked at the soft drink habits of ... from 1996 to 2002. The investigators found a link ...
... 2010 The Joint Commission has certified UT Southwestern ... Center, a distinction for hospitals fostering specialized stroke care ... imaging specialists, nurses and technicians have ready access to ... or after a stroke. Each year about 700,000 people ...
... breast imaging exams may increase a woman,s risk of ... online and in the October issue of Radiology ... are very low. "A single breast-specific gamma imaging ... lifetime risk of inducing fatal cancer greater than or ...
... 2010) While success is surely sweeter than failure, it ... fail spectacularly often flourish more in the long run, ... of management at the University of Colorado Denver Business School. ... Journal , focused on companies and organizations that launch satellites, ...
Cached Medicine News:Health News:Scientists Dismayed by Stem Cell Research Ruling 2Health News:Scientists Dismayed by Stem Cell Research Ruling 3Health News:Fat distribution plays a role in weight loss success in patients at risk of diabetes 2Health News:Study Suggests Link Between Diet Sodas, Preterm Delivery 2Health News:Study Suggests Link Between Diet Sodas, Preterm Delivery 3Health News:UT Southwestern University Hospital -- St. Paul recognized as Primary Stroke Center 2Health News:UT Southwestern University Hospital -- St. Paul recognized as Primary Stroke Center 3Health News:New nuclear breast imaging technologies associated with higher cancer risks 2Health News:New nuclear breast imaging technologies associated with higher cancer risks 3Health News:University of Colorado Denver Business School study shows failure better teacher than success 2
Rapid reagent impregnated disk test for presumptive identification of Candida albicans....
... Electronic Medical Records for small and large ... from check-in to check-out. Review the complete ... medications, to allergies, labs and charts all ... your patient records immediately. Communicate electronically with ...
... Written specifically for urologists by ... utilizes touch screen technology to ... eliminate the use of a ... makes using an EMR faster ...
... a new generation of advanced Electronic Medical ... the largest, numerically codified medical vocabularies in ... data elements embedded in MedcomSoft Record, healthcare ... an easy and intuitive point and click ...
Medicine Products: